Michael F. O‘Neill

Author

Michael F. O‘Neill

Also Known As

M B O'Neill, M B Oneill, M F O'Neill, M F O’Neill, M F O’Neill,, M O"Neill, M O'Neill, M ONeill, M O’Neill, M. Brendan O'Neill

308

Publications

3.3K

Citations

H-Index

158

Concepts

All Affiliations

Eli Lilly (United Kingdom)Eli Lilly (United States)The University of Queensland Department of Agriculture, Fisheries and Forestry Almirall (Spain)

About

Michael F. O‘Neill is an author at Eli Lilly (United Kingdom) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	2.1K
2	Health Sciences	10	11	829
3	Engineering	8	8	120
4	Business	3	3	44
5	Management	1	1	11

Michael F. O‘Neill

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat Colin T. Dourish, Michael F. O‘Neill, J. Coughlan, European Journal of Pharmacology Molecular PharmacologyHealth SciencesPain MedicineMedicineMolecular Pain	1990	269
5-HT2 Receptor Antagonism Reduces Hyperactivity Induced by Amphetamine, Cocaine, and MK-801 But Not D1 Agonist C-APB Michael F. O‘Neill, Claire Heron-Maxwell, Gillian Shaw Pharmacology Biochemistry and Behavior Functional SelectivityAddictionD1 Agonist C-apbPhysiologyMedicine	1999	136
The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism Mercè Correa, Anna Wisniecki, Adrienne J. Betz, Behavioural Brain Research NeurophysiologyNeuroanatomyLocomotor SuppressionPhysiologyMedicine	2003	134
Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D 1 agonist C-APB in mice Michael F. O‘Neill, Gillian Shaw Psychopharmacology Functional SelectivityAddictionMedicinePhysiologyPsychopharmacology	1999	121
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework Jean Bousquet, Diana Kuh, M. Bewick, The journal of nutrition health & aging Quality Of LifeAgingHealthy AgeingHealthy AgingLongevity	2015	102
Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats Michael F. O‘Neill, Colin T. Dourish, Susan D. Iversen Psychopharmacology Molecular PharmacologyPsychoactive DrugAddictionMedicinePhysiology	1991	95
Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial Brian W. McCrindle, Michael F. O‘Neill, Geraldine Cullen-Dean, The Journal of Pediatrics Lipid DisorderCrossover TrialPediatricsHyperlipidemiaChild Nutrition	1997	94
Role of 5-HT1A and 5-HT1B Receptors in the Mediation of Behavior in the Forced Swim Test in Mice Michael F. O‘Neill Neuropsychopharmacology Behavioral SciencesBehavioral NeurosciencePhysiologyNeuroendocrine MechanismNeuropharmacology	2001	92
Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo A. Bond, Nicole M. Jones, C A Hicks, Journal of Pharmacology and Experimental Therapeutics	2000	92
Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329 Michael F. O‘Neill, Colin T. Dourish, Susan D. Iversen Neuropharmacology AnalgesicsPain MedicineMedicinePhysiologyNeuropathic Pain	1989	87

Page 1